1
Novartis AG
0 1 2 3 4 5
4.52
2
GSK plc
0 1 2 3 4 5
4.48
3
Bayer AG
0 1 2 3 4 5
4.32
4
Bristol Myers Squibb
0 1 2 3 4 5
4.16
4
Novo Nordisk A/S
0 1 2 3 4 5
4.16
4
Roche Holding AG
0 1 2 3 4 5
4.16
7
Sanofi
0 1 2 3 4 5
4.12
7
Takeda Pharmaceutical Co, Ltd
0 1 2 3 4 5
4.12
9
Boehringer Ingelheim
0 1 2 3 4 5
4.00
10
Merck KGaA
0 1 2 3 4 5
3.80
10
Pfizer Inc
0 1 2 3 4 5
3.80
12
AstraZeneca plc
0 1 2 3 4 5
3.64
13
Eisai Co, Ltd
0 1 2 3 4 5
3.60
14
Johnson & Johnson
0 1 2 3 4 5
3.40
15
Astellas Pharma Inc
0 1 2 3 4 5
3.28
16
Daiichi Sankyo Co, Ltd
0 1 2 3 4 5
2.96
17
Eli Lilly & Co
0 1 2 3 4 5
2.80
18
Merck & Co, Inc
0 1 2 3 4 5
2.68
19
Gilead Sciences
0 1 2 3 4 5
2.60
20
AbbVie Inc
0 1 2 3 4 5
2.60
0 1 2 3 4 5

The ranking above shows the position and score of each company in the 2026 Index (left) and 2024 Index (right). Click on a company's name to go to its full report card.